This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ARIAD Pharmaceuticals Inc (ARIA)

NASDAQ: Health Care

Insider Trading
Historical Data Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago 4 Mo. Ago 5 Mo. Ago 6 Mo. Ago
Net Insider Transaction 103,108 16,304 50,430 -123,766 -12,968 198,767 447,798
Shares Bought 232,100 99,600 159,600 60,000 416,447 722,820 848,085
Shares Sold 128,992 83,296 109,170 183,766 429,415 524,053 400,287
Institutional Trading
Historical Data Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago 4 Mo. Ago 5 Mo. Ago 6 Mo. Ago
Total Shares Held 141.44M 146.05M 147.94M 138.57M 138.57M 138.57M 134.18M
Shares Bought 24.79M 25.25M 26.09M 8.48M 8.48M 8.48M 17.86M
Shares Sold 16.22M 15.42M 14.81M 17.63M 17.63M 17.63M 19.98M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ARIA ARIAD Pharmaceuticals Inc

Chart of ARIA

Analysts Ratings for ARIA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 3 3 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ARIA Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs